Abel Hall LLC’s Cidara Therapeutics CDTX Stock Holding History

Abel Hall LLC’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,069	Closed	-$236K	–	842
2025 Q4	$236K	Buy	+1,069	New	+$173K	0.06%	458

Abel Hall LLC's CDTX Position: Q1 2026 in Review

Abel Hall LLC sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,069 shares — an estimated $236K sold.

Abel Hall LLC first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $236K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Abel Hall LLC reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 1,069 Cidara Therapeutics shares in Q1 2026, an estimated $236K.
Abel Hall LLC first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's Cidara Therapeutics position peaked at $236K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.